 | • レポートコード：QYR9N7596 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、ムコール真菌症のグローバル市場について調査・分析したレポートで、種類別（リゾプス、リゾムコール、クスダマカビ、アポフィソミセス、サクセニア、その他）、用途別（病院と診療所、医療機関、研究機関）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・ムコール真菌症の世界市場規模 ・主要企業別市場シェア ・ムコール真菌症の世界市場規模：種類別（リゾプス、リゾムコール、クスダマカビ、アポフィソミセス、サクセニア、その他） ・ムコール真菌症の世界市場規模：用途別（病院と診療所、医療機関、研究機関） ・ムコール真菌症のアメリカ市場規模（種類別、用途別） ・ムコール真菌症のヨーロッパ市場規模（種類別、用途別） ・ムコール真菌症の中国市場規模（種類別、用途別） ・ムコール真菌症の日本市場規模（種類別、用途別） ・ムコール真菌症の東南アジア市場規模（種類別、用途別） ・ムコール真菌症のインド市場規模（種類別、用途別） ・ムコール真菌症の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・ムコール真菌症の世界市場予測（2019年-2025年） ・ムコール真菌症の地域別市場予測（2019年-2025年） ... |
Mucormycosis is any fungal infection caused by fungi in the order Mucorales. Generally, species in the Mucor, Rhizopus, Absidia, and Cunninghamella genera are most often implicated. The disease is often characterized by hyphae growing in and around blood vessels and can be potentially life-threatening in diabetic or severely immunocompromised individuals.If mucormycosis is suspected, amphotericin B therapy should be immediately administered due to the rapid spread and high mortality rate of the disease. Amphotericin B is usually administered for an additional 4–6 weeks after initial therapy begins to ensure eradication of the infection. After administration of either amphotericin B or posaconazole, surgical removal of the “fungus ball” is indicated. The disease must be monitored carefully for any signs of reemergence.
In 2018, the global Mucormycosis market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Mucormycosis status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Mucormycosis development in United States, Europe and China.
The key players covered in this study
Abbott Laboratories
Biocon
Cadila Pharmaceuticals
Novartis
Merck
Roche
Bristol Myers Squibb
Pfizer
Market segment by Type, the product can be split into
Rhizopus
Rhizomucor
Cunninghamella
Apophysomyces
Saksenaea
Lichtheimia (Absidia)
Mucor
Market segment by Application, split into
Hospitals & Clinics
Medical Institutes
Research Organization
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Mucormycosis status, future forecast, growth opportunity, key market and key players.
To present the Mucormycosis development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Mucormycosis are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Mucormycosis Market Size Growth Rate by Type (2014-2025)
1.4.2 Rhizopus
1.4.3 Rhizomucor
1.4.4 Cunninghamella
1.4.5 Apophysomyces
1.4.6 Saksenaea
1.4.7 Lichtheimia (Absidia)
1.4.8 Mucor
1.5 Market by Application
1.5.1 Global Mucormycosis Market Share by Application (2014-2025)
1.5.2 Hospitals & Clinics
1.5.3 Medical Institutes
1.5.4 Research Organization
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Mucormycosis Market Size
2.2 Mucormycosis Growth Trends by Regions
2.2.1 Mucormycosis Market Size by Regions (2014-2025)
2.2.2 Mucormycosis Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Mucormycosis Market Size by Manufacturers
3.1.1 Global Mucormycosis Revenue by Manufacturers (2014-2019)
3.1.2 Global Mucormycosis Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Mucormycosis Market Concentration Ratio (CR5 and HHI)
3.2 Mucormycosis Key Players Head office and Area Served
3.3 Key Players Mucormycosis Product/Solution/Service
3.4 Date of Enter into Mucormycosis Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Mucormycosis Market Size by Type (2014-2019)
4.2 Global Mucormycosis Market Size by Application (2014-2019)
5 United States
5.1 United States Mucormycosis Market Size (2014-2019)
5.2 Mucormycosis Key Players in United States
5.3 United States Mucormycosis Market Size by Type
5.4 United States Mucormycosis Market Size by Application
6 Europe
6.1 Europe Mucormycosis Market Size (2014-2019)
6.2 Mucormycosis Key Players in Europe
6.3 Europe Mucormycosis Market Size by Type
6.4 Europe Mucormycosis Market Size by Application
7 China
7.1 China Mucormycosis Market Size (2014-2019)
7.2 Mucormycosis Key Players in China
7.3 China Mucormycosis Market Size by Type
7.4 China Mucormycosis Market Size by Application
8 Japan
8.1 Japan Mucormycosis Market Size (2014-2019)
8.2 Mucormycosis Key Players in Japan
8.3 Japan Mucormycosis Market Size by Type
8.4 Japan Mucormycosis Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Mucormycosis Market Size (2014-2019)
9.2 Mucormycosis Key Players in Southeast Asia
9.3 Southeast Asia Mucormycosis Market Size by Type
9.4 Southeast Asia Mucormycosis Market Size by Application
10 India
10.1 India Mucormycosis Market Size (2014-2019)
10.2 Mucormycosis Key Players in India
10.3 India Mucormycosis Market Size by Type
10.4 India Mucormycosis Market Size by Application
11 Central & South America
11.1 Central & South America Mucormycosis Market Size (2014-2019)
11.2 Mucormycosis Key Players in Central & South America
11.3 Central & South America Mucormycosis Market Size by Type
11.4 Central & South America Mucormycosis Market Size by Application
12 International Players Profiles
12.1 Abbott Laboratories
12.1.1 Abbott Laboratories Company Details
12.1.2 Company Description and Business Overview
12.1.3 Mucormycosis Introduction
12.1.4 Abbott Laboratories Revenue in Mucormycosis Business (2014-2019)
12.1.5 Abbott Laboratories Recent Development
12.2 Biocon
12.2.1 Biocon Company Details
12.2.2 Company Description and Business Overview
12.2.3 Mucormycosis Introduction
12.2.4 Biocon Revenue in Mucormycosis Business (2014-2019)
12.2.5 Biocon Recent Development
12.3 Cadila Pharmaceuticals
12.3.1 Cadila Pharmaceuticals Company Details
12.3.2 Company Description and Business Overview
12.3.3 Mucormycosis Introduction
12.3.4 Cadila Pharmaceuticals Revenue in Mucormycosis Business (2014-2019)
12.3.5 Cadila Pharmaceuticals Recent Development
12.4 Novartis
12.4.1 Novartis Company Details
12.4.2 Company Description and Business Overview
12.4.3 Mucormycosis Introduction
12.4.4 Novartis Revenue in Mucormycosis Business (2014-2019)
12.4.5 Novartis Recent Development
12.5 Merck
12.5.1 Merck Company Details
12.5.2 Company Description and Business Overview
12.5.3 Mucormycosis Introduction
12.5.4 Merck Revenue in Mucormycosis Business (2014-2019)
12.5.5 Merck Recent Development
12.6 Roche
12.6.1 Roche Company Details
12.6.2 Company Description and Business Overview
12.6.3 Mucormycosis Introduction
12.6.4 Roche Revenue in Mucormycosis Business (2014-2019)
12.6.5 Roche Recent Development
12.7 Bristol Myers Squibb
12.7.1 Bristol Myers Squibb Company Details
12.7.2 Company Description and Business Overview
12.7.3 Mucormycosis Introduction
12.7.4 Bristol Myers Squibb Revenue in Mucormycosis Business (2014-2019)
12.7.5 Bristol Myers Squibb Recent Development
12.8 Pfizer
12.8.1 Pfizer Company Details
12.8.2 Company Description and Business Overview
12.8.3 Mucormycosis Introduction
12.8.4 Pfizer Revenue in Mucormycosis Business (2014-2019)
12.8.5 Pfizer Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Mucormycosis Key Market Segments
Table Key Players Mucormycosis Covered
Table Global Mucormycosis Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Mucormycosis Market Size Market Share by Type 2014-2025
Figure Rhizopus Figures
Table Key Players of Rhizopus
Figure Rhizomucor Figures
Table Key Players of Rhizomucor
Figure Cunninghamella Figures
Table Key Players of Cunninghamella
Figure Apophysomyces Figures
Table Key Players of Apophysomyces
Figure Saksenaea Figures
Table Key Players of Saksenaea
Figure Lichtheimia (Absidia) Figures
Table Key Players of Lichtheimia (Absidia)
Figure Mucor Figures
Table Key Players of Mucor
Table Global Mucormycosis Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospitals & Clinics Case Studies
Figure Medical Institutes Case Studies
Figure Research Organization Case Studies
Figure Mucormycosis Report Years Considered
Table Global Mucormycosis Market Size 2014-2025 (Million US$)
Figure Global Mucormycosis Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Mucormycosis Market Size by Regions 2014-2025 (Million US$)
Table Global Mucormycosis Market Size by Regions 2014-2019 (Million US$)
Table Global Mucormycosis Market Share by Regions 2014-2019
Figure Global Mucormycosis Market Share by Regions 2014-2019
Figure Global Mucormycosis Market Share by Regions 2019
Table Market Top Trends
Table Global Mucormycosis Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Mucormycosis Market Share by Manufacturers (2014-2019)
Figure Global Mucormycosis Market Share by Manufacturers in 2018
Table Global Mucormycosis Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Mucormycosis Product/Solution/Service
Table Date of Enter into Mucormycosis Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Mucormycosis Market Size by Type (2014-2019) (Million US$)
Table Global Mucormycosis Market Size Share by Type (2014-2019)
Figure Global Mucormycosis Market Size Market Share by Type (2014-2019)
Table Global Mucormycosis Market Size by Application (2014-2019) (Million US$)
Table Global Mucormycosis Market Size Share by Application (2014-2019)
Figure Global Mucormycosis Market Size Market Share by Application (2014-2019)
Figure Global Mucormycosis Revenue Market Share by Application in 2018
Figure United States Mucormycosis Market Size 2014-2019 (Million US$)
Table United States Key Players Mucormycosis Revenue (2018-2019) (Million US$)
Table United States Key Players Mucormycosis Market Share (2018-2019)
Table United States Mucormycosis Market Size by Type (2014-2019) (Million US$)
Table United States Mucormycosis Market Share by Type (2014-2019)
Table United States Mucormycosis Market Size by Application (2014-2019) (Million US$)
Table United States Mucormycosis Market Share by Application (2014-2019)
Figure Europe Mucormycosis Market Size 2014-2019 (Million US$)
Table Europe Key Players Mucormycosis Revenue (2018-2019) (Million US$)
Table Europe Key Players Mucormycosis Market Share (2018-2019)
Table Europe Mucormycosis Market Size by Type (2014-2019) (Million US$)
Table Europe Mucormycosis Market Share by Type (2014-2019)
Table Europe Mucormycosis Market Size by Application (2014-2019) (Million US$)
Table Europe Mucormycosis Market Share by Application (2014-2019)
Figure China Mucormycosis Market Size 2014-2019 (Million US$)
Table China Key Players Mucormycosis Revenue (2018-2019) (Million US$)
Table China Key Players Mucormycosis Market Share (2018-2019)
Table China Mucormycosis Market Size by Type (2014-20189) (Million US$)
Table China Mucormycosis Market Share by Type (2014-2019)
Table China Mucormycosis Market Size by Application (2014-2019) (Million US$)
Table China Mucormycosis Market Share by Application (2014-2019)
Figure Japan Mucormycosis Market Size 2014-2019 (Million US$)
Table Japan Key Players Mucormycosis Revenue (2018-2019) (Million US$)
Table Japan Key Players Mucormycosis Market Share (2018-2019)
Table Japan Mucormycosis Market Size by Type (2014-2019) (Million US$)
Table Japan Mucormycosis Market Share by Type (2014-2019)
Table Japan Mucormycosis Market Size by Application (2014-2019) (Million US$)
Table Japan Mucormycosis Market Share by Application (2014-2019)
Figure Southeast Asia Mucormycosis Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Mucormycosis Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Mucormycosis Market Share (2018-2019)
Table Southeast Asia Mucormycosis Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Mucormycosis Market Share by Type (2014-2019)
Table Southeast Asia Mucormycosis Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Mucormycosis Market Share by Application (2014-2019)
Figure India Mucormycosis Market Size 2014-2019 (Million US$)
Table India Key Players Mucormycosis Revenue (2018-2019) (Million US$)
Table India Key Players Mucormycosis Market Share (2018-2019)
Table India Mucormycosis Market Size by Type (2014-2019) (Million US$)
Table India Mucormycosis Market Share by Type (2014-2019)
Table India Mucormycosis Market Size by Application (2014-2019) (Million US$)
Table India Mucormycosis Market Share by Application (2014-2019)
Figure Central & South America Mucormycosis Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Mucormycosis Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Mucormycosis Market Share (2018-2019)
Table Central & South America Mucormycosis Market Size by Type (2014-2019) (Million US$)
Table Central & South America Mucormycosis Market Share by Type (2014-2019)
Table Central & South America Mucormycosis Market Size by Application (2014-2019) (Million US$)
Table Central & South America Mucormycosis Market Share by Application (2014-2019)
Table Abbott Laboratories Company Details
Table Abbott Laboratories Revenue in Mucormycosis Business (2014-2019) (Million US$)
Figure Abbott Laboratories Revenue Growth Rate in Mucormycosis Business (2014-2019)
Table Abbott Laboratories Recent Development
Table Biocon Company Details
Table Biocon Revenue in Mucormycosis Business (2014-2019)(Million US$)
Figure Biocon Revenue Growth Rate in Mucormycosis Business (2014-2019)
Table Biocon Recent Development
Table Cadila Pharmaceuticals Company Details
Table Cadila Pharmaceuticals Revenue in Mucormycosis Business (2014-2019)(Million US$)
Figure Cadila Pharmaceuticals Revenue Growth Rate in Mucormycosis Business (2014-2019)
Table Cadila Pharmaceuticals Recent Development
Table Novartis Company Details
Table Novartis Revenue in Mucormycosis Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Mucormycosis Business (2014-2019)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Revenue in Mucormycosis Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Mucormycosis Business (2014-2019)
Table Merck Recent Development
Table Roche Company Details
Table Roche Revenue in Mucormycosis Business (2014-2019)(Million US$)
Figure Roche Revenue Growth Rate in Mucormycosis Business (2014-2019)
Table Roche Recent Development
Table Bristol Myers Squibb Company Details
Table Bristol Myers Squibb Revenue in Mucormycosis Business (2014-2019)(Million US$)
Figure Bristol Myers Squibb Revenue Growth Rate in Mucormycosis Business (2014-2019)
Table Bristol Myers Squibb Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Mucormycosis Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Mucormycosis Business (2014-2019)
Table Pfizer Recent Development
Table Global Mucormycosis Market Size by Regions (Million US$) 2019-2025
Figure Global Mucormycosis Market Size Share by Regions (2019-2025)
Figure Global Mucormycosis Market Size Share by Regions in 2025
Figure United States Mucormycosis Market Size Forecast (2019-2025)(Million USD)
Figure Europe Mucormycosis Market Size Forecast (2019-2025)(Million USD)
Figure China Mucormycosis Market Size Forecast (2019-2025)(Million USD)
Figure Japan Mucormycosis Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Mucormycosis Market Size Forecast (2019-2025)(Million USD)
Figure India Mucormycosis Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Mucormycosis Market Size Forecast (2019-2025)(Million USD)
Table Global Mucormycosis Market Size by Product (2019-2025) (Million US$)
Figure Global Mucormycosis Market Size by Product (2019-2025)
Figure Global Mucormycosis Market Size by Product in 2025
Table Global Mucormycosis Market Size by Application (2019-2025) (Million US$)
Figure Global Mucormycosis Market Size by Application (2019-2025)
Figure Global Mucormycosis Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の受託研究機関市場：市場規模・現状・予測 A contract research organization is a company that provides support to the pharmaceutical, biotechnology and medical device industries in the form of research services outsourced on a contract basis.A CRO may provide such services as biopharmaceutical development, biologic assay development, commerc…- 世界の生体内契約研究機関市場：市場規模・現状・予測 In-vivo contract research organizations (CROs) are those institutions engaged in biopharmaceutical research on a contractual basis. With the growing popularity of biologics over small molecule drugs, the popularity of in-vivo CROs are gaining traction. With increasing demand for clinical scale manuf…
- 世界の心膜炎市場：市場規模・現状・予測 Pericarditis is inflammation of the pericardium (the fibrous sac surrounding the heart). Symptoms typically include sudden onset of sharp chest pain. The pain may also be felt in the shoulders, neck, or back. It is typically better sitting up and worse with lying down or breathing deep. Other sympto…
- 世界の外来診療所市場：市場規模・現状・予測 The outpatient clinics has continued to play a significant role in management of the cognitive behavioral disorders. High-risk situations such as substance abuse, sexual offence, depression, obesity and obsessive-compulsive behavior is becoming a major concern in various countries. Management of hig…
- 世界の原発性アルドステロン症市場：市場規模・現状・予測 Primary aldosteronism refers to the excess production of the hormone aldosterone from the adrenal glands, resulting in low renin levels. This abnormality is caused by hyperplasia or tumors. Many suffer from fatigue, potassium deficiency and high blood pressure which may cause poor vision, confusion …